• US chip stocks were smashed overnight. So why are ASX tech shares rising?

    the australian flag lies alongside the united states flag on a flat surface.

    ASX investors were handed a rough lead from Wall Street overnight after US chip stocks were heavily sold down.

    The sell-off was centred on some of the biggest names in the artificial intelligence (AI) trade, with investors taking profits after a very strong run.

    Overnight, the Nasdaq Composite Index (NASDAQ: .IXIC) fell 2.2%, while the Philadelphia Semiconductor Index (NASDAQ: SOX) dropped 7.9%.

    Some of the bigger falls came from the names that have been riding the AI boom.

    Micron Technology Inc (NASDAQ: MU) dropped 13% to US$1,051.77, Nvidia Corp (NASDAQ: NVDA) fell 4.1% to US$200.04, while Qualcomm Inc (NASDAQ: QCOM) and Marvell Technology Inc (NASDAQ: MRVL) lost 8% and 9.4%, respectively.

    While this might sound like a warning sign for ASX tech shares, the local market has gone the other way today.

    At the time of writing, several large ASX tech shares are trading higher, despite the weak US lead.

    So, why are ASX tech shares rising?

    ASX tech shares move higher

    The main reason is that ASX tech shares aren’t really chip stocks.

    The overnight selling was focused on US companies closely tied to semiconductors, memory chips, and AI infrastructure.

    And that is not quite the same as our local tech sector.

    Xero Ltd (ASX: XRO) is an accounting software business. WiseTech Global Ltd (ASX: WTC) provides logistics software, while Pro Medicus Ltd (ASX: PME) sells medical imaging software.

    So, while the US sell-off is clearly worth watching, it doesn’t directly change the outlook for most ASX tech names.

    There also appears to be some bargain hunting going on.

    A number of local tech shares have already been hit hard in 2026, with Xero and WiseTech both under heavy pressure recently.

    At the time of writing, Xero shares are up 7.1% to $69.63, while WiseTech shares are up 13.42% to $32.62.

    Pro Medicus shares are 2.1% higher at $176.75, and NextDC Ltd (ASX: NXT) shares are up 2.20% to $14.85.

    What should ASX investors watch now?

    The key thing to watch is whether the selling stays in US chip stocks or starts spreading across the broader US tech sector.

    If investors keep taking money out of the AI trade, ASX growth shares could still feel some pressure, especially those trading on higher valuations.

    But for now, the local market is holding up reasonably well.

    And that is likely because many ASX tech shares have already had a difficult run in 2026.

    Xero and WiseTech, in particular, are both still well below where they were a year ago, despite today’s bounce.

    The post US chip stocks were smashed overnight. So why are ASX tech shares rising? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Marvell Technology, Micron Technology, Nvidia, Qualcomm, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Nvidia and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why Aurelia Metals, Beach Energy, IAG, and Rio Tinto shares are falling today

    A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.

    The S&P/ASX 200 Index (ASX: XJO) is having a better day on Wednesday. In afternoon trade, the benchmark index is up 0.2% to 8,806 points.

    Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

    Aurelia Metals Ltd (ASX: AMI)

    The Aurelia Metals share price is down 5% to 29.5 cents. This morning, this gold miner announced that it has achieved financial close on a $150 million senior secured financing package. It notes that this strengthens its balance sheet and increases liquidity. The company’s chief financial officer, Martin Cummings, said: “This refinancing is the culmination of a deliberate strategy and comprehensive process to secure a highly competitive financing package with a flexible structure. The facilities strengthen Aurelia’s balance sheet, increase liquidity and provide long-term support for the Company’s rehabilitation bonding requirements. The strong level of interest received throughout the process enabled us to assemble a high-quality syndicate of global financial institutions that are well positioned to support Aurelia’s next phase of growth.”

    Beach Energy Ltd (ASX: BPT)

    The Beach Energy share price is down 7.5% to 87 cents. This is likely to have been driven by a broker note out of Morgans this morning. According to the note, the broker has downgraded the energy producer’s shares to a sell rating (from hold) with an 81 cents price target (from $1.10). It said: “We mark-to-market our second half estimates for weaker spot gas prices, while also trimming our Waitsia output forecasts for FY26-28 on continuing struggles. After downgrading our Q4 estimates for daily production rates, we see potential for BPT to fall just short of its FY27 group production guidance. While BPT’s share price has already been under pressure, its earnings outlook has declined at a faster rate, with its forward EV/EBITDA actually rising.”

    Insurance Australia Group Ltd (ASX: IAG)

    The IAG share price is down 4% to $7.95. This could also have been driven by a broker note. This morning, Macquarie downgraded the insurance giant’s shares to a neutral rating (from outperform) with a reduced price target of $8.50 (from $9.00). It made the move on the belief that AI could disrupt insurance providers.

    Rio Tinto Ltd (ASX: RIO)

    The Rio Tinto share price is down 2% to $172.37. Investors have been selling the mining giant’s shares following a sizeable pullback in the copper price overnight. This led to significant weakness in the miner’s NYSE listed shares on Wall Street on Tuesday night.

    The post Why Aurelia Metals, Beach Energy, IAG, and Rio Tinto shares are falling today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Aurelia Metals right now?

    Before you buy Aurelia Metals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aurelia Metals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Metrics Master Income Trust announces June 2026 monthly payout

    Man holding Australian dollar notes, symbolising dividends.

    The Metrics Master Income Trust (ASX: MXT) share price is on watch today as the fund announced a monthly unfranked distribution of 1.36 cents per unit for June 2026.

    What did Metrics Master Income Trust report?

    • Monthly distribution declared: 1.36 cents per unit (unfranked)
    • Ex-date: 30 June 2026; Record date: 1 July 2026; Payment date: 8 July 2026
    • Distribution relates to the period ending 30 June 2026
    • Distribution Reinvestment Plan (DRP) available, with elections due by 2 July 2026
    • DRP discount: Nil (0%)

    What else do investors need to know?

    The distribution is fully unfranked, which means investors may want to consider the potential tax implications. Holders who wish to reinvest their distributions can participate in the fund’s DRP, with no discount being offered. Those who do not elect to participate will receive their payments in cash.

    The DRP price will be calculated as set out in the fund’s constitution, and new DRP units will rank equally with existing units. Investors have until 5:00 pm (AEST) on 2 July 2026 to lodge their DRP election.

    What’s next for Metrics Master Income Trust?

    Metrics Master Income Trust continues its regular monthly payout approach, aiming to provide consistent income to its unitholders. Investors should keep an eye on future announcements for any changes to distribution rates or franking status.

    The fund’s ongoing distributions remain a key focus, and the trust’s team will likely update the market regarding its investment performance and outlook in subsequent reports.

    Metrics Master Income Trust share price snapshot

    Over the past 12 months, Metrics Master Income Trust shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

    View Original Announcement

    The post Metrics Master Income Trust announces June 2026 monthly payout appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Metrics Master Income Trust right now?

    Before you buy Metrics Master Income Trust shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Metrics Master Income Trust wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • The list of market resources pinned to the top of the sub has been updated!

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.